Monthly Archives: January 2015

Imperial Capital Believes This Stock Won’t Stop Here

Imperial Capital analyst Bob McAdoo maintained an Outperform rating on JetBlue Airways (NASDAQ: JBLU) today and set a price target of $20. The company’s shares opened today at $16.79, close to its 52-week high of $17.25. Mcadoo observed, “We are

IAC/InterActiveCorp Receives a Sector Perform from RBC Capital

In a report released today, Mark Mahaney from RBC Capital maintained a Sector Perform rating on IAC/InterActiveCorp (NASDAQ: IACI), with a price target of $70. The company’s shares opened today at $60.95. IAC/InterActiveCorp has an analyst consensus of Hold, with

Constant Contact Recieved its Third Buy in a Row

After Credit Suisse and Canaccord Genuity assigned a Buy rating to Constant Contact in the last month, the company received another Buy, this time from Roth Capital. Analyst Richard Baldry maintained a Buy rating on Constant Contact (NASDAQ: CTCT) today

BioMarin Receives a Neutral from Wedbush

Wedbush analyst Liana Moussatos reiterated a Neutral rating on BioMarin (NASDAQ: BMRN) today and set a price target of $102. The company’s shares opened today at $97.16, close to its 52-week high of $100.95. Moussatos observed, “BioMarin announced completion of

Roth Capital Reiterates a Buy Rating on bluebird bio

In a report released today, Debjit Chattopadhyay from Roth Capital reiterated a Buy rating on bluebird bio (NASDAQ: BLUE), with a price target of $120. The company’s shares opened today at $92.91, close to its 52-week high of $106.23. Chattopadhyay

Roth Capital Maintains a Buy Rating on Iradimed Corp

In a report released today, Chris Lewis from Roth Capital maintained a Buy rating on Iradimed Corp (NASDAQ: IRMD), with a price target of $18. The company’s shares opened today at $14.64. Iradimed Corp has an analyst consensus of Strong